Folisurge 75IU

Folisurge 75IU injection contains Follitropin alfa as its active ingredient. This medication is utilized in assisted reproductive technologies (ART) to address infertility in both genders. As a synthetic version of follicle-stimulating hormone (FSH), it is essential for promoting the growth of eggs in women and sperm in men. Infertility, defined as the inability to conceive after one year of regular unprotected intercourse, affects both men and women. The injection encourages the development of multiple follicles in women, boosts sperm production in men, and ensures precise timing for optimal ovulation. With established effectiveness and a generally safe profile, it offers hope to couples facing infertility, enhancing pregnancy rates and reducing treatment duration.

Those with known hypersensitivity or allergic reactions to Folisurge 75IU injection or any of its ingredients should refrain from using it. Although allergic reactions are uncommon, they can occur and necessitate immediate medical intervention. Women with ovarian cysts or tumors should avoid this injection, as it may worsen these conditions. Patients suffering from uncontrolled hypothyroidism or adrenal dysfunction should not use Folisurge 75IU injection. Uncontrolled hypothyroidism is characterized by inadequately regulated thyroid hormone levels, leading to persistent symptoms and possible complications. Additionally, individuals with reproductive tract abnormalities or blockages that hinder the successful transport of eggs or sperm may not find this medication beneficial. It is also not typically recommended for pediatric or elderly populations.